Related:
* Alpharma, Inc.
* , King Pharmaceuticals Inc.
BRISTOL, Tenn. & BRIDGEWATER, N.J. King Pharmaceuticals, Inc. and Alpharma Inc. announced that the U.S. Federal Trade Commission has provisionally accepted a proposed consent order for public comment and has terminated the Hart-Scott-Rodino waiting period applicable to King’s proposed acquisition of Alpharma.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment